Deana Mohr-Haralampieva

Deana Mohr-Haralampieva is currently the CEO & co-founder of MUVON Therapeutics AG. Prior to this role, Deana worked as a Project Leader at Wyss Zurich and as a UZH Entrepreneur Fellow at the University of Zurich. Deana has a background in urologic tissue engineering, stem cell therapy, and pharmaceutical sciences. Deana holds a Dr.sc.ETH degree from ETH Zurich in Radiopharmaceutical Sciences, Tissue Engineering, and Stem Cell Therapies. Deana also has a Master's degree in Cellular and Molecular Biology from the University of Konstanz, where Deana previously worked as a Laboratory Assistant and Research Associate. Deana's expertise includes clinical research, project management, grant writing, and coordination of international consortiums.